Cargando…

Design and Synthesis of Neutralizable Fondaparinux

[Image: see text] Fondaparinux, a clinically approved anticoagulant pentasaccharide for the treatment of thrombotic diseases, displays better efficacy and biosafety than other heparin-based anticoagulant drugs. However, there is no suitable antidote available for fondaparinux to efficiently manage i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Liangwei, Liu, Yating, Xu, Zhuojia, Hao, Tianhui, Wang, Peng George, Zhao, Wei, Li, Tiehai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795572/ https://www.ncbi.nlm.nih.gov/pubmed/36590263 http://dx.doi.org/10.1021/jacsau.2c00537

Ejemplares similares

A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice
por: Nagano, Masanobu, et al.
Publicado: (2023)

Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX
por: Wakui, Koji, et al.
Publicado: (2019)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Divergent Enzymatic Assembly of a Comprehensive 64‐Membered IgG N‐Glycan Library for Functional Glycomics
por: Ma, Wenjing, et al.
Publicado: (2023)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
por: Walke, Gulab, et al.
Publicado: (2021)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Probable fondaparinux-associated bullous hemorrhagic dermatosis
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

Novel self assembling nanoparticles for the oral administration of fondaparinux: Synthesis, characterization and in vivo evaluation
por: Ralay-Ranaivo, Bettina, et al.
Publicado: (2014)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Fondaparinux: A cornerstone drug in acute coronary syndromes
por: Khan, Mohammed Yunus, et al.
Publicado: (2022)

Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
por: Marongiu, Francesco, et al.
Publicado: (2020)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Dermatose bulleuse hémorragique probablement associée au fondaparinux
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)

Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

Use of Molecular Dynamics for the Refinement of an Electrostatic Model for the In Silico Design of a Polymer Antidote for the Anticoagulant Fondaparinux
por: Cajiao, Adriana, et al.
Publicado: (2013)

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
por: Turpie, Alexander GG
Publicado: (2006)

Fondaparinux–Associated Rectus Sheath Hematoma: Skating on Thin Ice
por: Sabanis, Nikolaos, et al.
Publicado: (2020)

Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
por: He, Yumiao, et al.
Publicado: (2018)

Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release
por: Laurent, Marc, et al.
Publicado: (2014)

Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
por: Schiele, François
Publicado: (2010)

Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study
por: Ramadan, Alyaa, et al.
Publicado: (2011)

Spontaneous acute subdural hematoma due to fondaparinux: Report of two cases
por: Fryburg, Karsten, et al.
Publicado: (2011)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Amato, Bruno, et al.
Publicado: (2016)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2016)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study
por: Wang, Lei, et al.
Publicado: (2023)

Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series
por: Tanguay, Mégane, et al.
Publicado: (2022)

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
por: Bergqvist, David
Publicado: (2006)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Risk factors for bleeding in patients receiving fondaparinux after colorectal cancer surgery
por: Pak, Jongsung, et al.
Publicado: (2018)

AZD-1222/fondaparinux sodium: Thrombotic thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
por: Dempfle, Carl-Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5hfi7tpbiaqo2t90i3voap5htk